Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-03-03
2010-11-16
Solola, Taofiq A (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S272100
Reexamination Certificate
active
07834036
ABSTRACT:
Fused aromatic compounds of Formula (I) are PPAR gamma agonists or partial agonists and are useful in the treatment or control of type II diabetes, including hyperglycemia, dyslipidermia, hyperlipidemia, hypercholesterolemia, hypertriglyceridemia, and obesity that are often associated with type 2 diabetes.
REFERENCES:
patent: WO 01/30343 (2001-05-01), None
patent: WO 01/060807 (2001-08-01), None
patent: WO 01/079197 (2001-10-01), None
patent: WO 02/08188 (2002-01-01), None
patent: WO 02/010137 (2002-02-01), None
patent: WO 02/064094 (2002-08-01), None
patent: WO 2004/ 014860 (2004-02-01), None
patent: WO 2004/019869 (2004-03-01), None
patent: WO 2004/020408 (2004-03-01), None
patent: WO 2004/020409 (2004-03-01), None
patent: WO 2006/033891 (2006-03-01), None
Meinke Peter T.
Shi Guo Q.
Wood Harold B.
Zhang Yong
Fair Janet E.
Merck Sharp & Dohme Corp
Solola Taofiq A
Todaro John C.
LandOfFree
Fused-aromatic compounds having anti-diabetic activity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Fused-aromatic compounds having anti-diabetic activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fused-aromatic compounds having anti-diabetic activity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4200364